28 November 2023
SHARE NOW
ATE
Cell Therapy
CMC
Gene Therapy
In this interview filmed at Advanced Therapies Europe 2023, David Sourdive discusses challenges in manufacturing science and technology specifically in the cell and gene therapy industry.
David Sourdive, Executive Vice President CMC & Manufacturing at Cellectis joins us for this interview to explore the challenges of manufacturing science and technology (MSAT), such as analytics, as well as the potential complexities in the processes of advancing MSAT for commercial production.
To watch more on the topic of MSAT with David, watch the session here >>
More like this
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Are you looking for a cost-effective, high-productivity extracellular vesicle (EV) production platform that overcomes traditional manufacturing challenges? Join us to discover how Univercells Technologies’ scalable fixed-bed design is transforming EV manufacturing.
14 May 2024
Women in Advanced Therapies Global 2024, Virtual Event
Experience Women in Advanced Therapies Global, a 24-hour online event uniting the community in celebration of inspiration, innovation, and empowerment. Access exclusive insights, workshops, and networking opportunities from anywhere.
8 April 2024
